MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    The Prevalence of Primary Tauopathies in Ireland; a Clinically-Defined Study in the Province of Leinster: design and initial data.

    S. Lyons, R. Walsh, T. Lynch, S. O'Dowd (Dublin 24, Ireland)

    Objective: To investigate the epidemiology and phenomenology of PSP and CBS within the province of Leinster. Background: PSP and CBS are uncommon parkinsonian disorders. Studies…
  • 2023 International Congress

    The specific application of a motor rehabilitation package in correcting the psycho-emotional sphere in patients with Parkinson’s disease.

    N. Voloshyna, I. Bogdanova, I. Voloshyn-Haponov (Kharkiv, Ukraine)

    Objective: The study aimed to investigate the effectiveness of a motor rehabilitation programme for 48 patients with Parkinson's disease using the phenomenon of paradoxical kinesia…
  • 2023 International Congress

    Relevance of amyloid deposition for REM sleep behavior disorder in Parkinson’s disease

    J. Pineda-Pardo, M. López-Aguirre, G. Pagano, V. Gnoni, K. Ray Chaudhuri, G. Logroscino, D. Urso (Madrid, Spain)

    Objective: In this study, we aimed to investigate the relationship between regional [18F]florbetaben PET binding to amyloid-β (Aβ) and REM sleep behavior disorder (RBD) in…
  • 2023 International Congress

    CSF tau reflects long-term outcome of patients with idiopathic normal pressure hydrocephalus: a longitudinal retrospective study.

    J. Bissacco, C. Simonetta, D. Mascioli, N. Mercuri, T. Schirinzi (Roma, Italy)

    Objective: To predict long-term clinical outcome of iNPH patients through a panel of neurodegeneration-related CSF biomarkers. Background: Idiopathic normal pressure hydrocephalus (iNPH) is a neurodegenerative…
  • 2023 International Congress

    The effects of dopaminergic treatment on interhemispheric disinhibition and bradykinesia asymmetry in Parkinson’s disease

    M. de Riggi, G. Paparella, M. Bologna, D. Colella, A. Cannavacciuolo, A. de Biase, D. Birreci, D. Costa, A. Guerra, A. Berardelli (Rome, Italy)

    Objective: to investigate whether dopaminergic therapy modulates IHI and bradykinesia asymmetry in PD. Background: previous evidence demonstrated a reduced interhemispheric inhibition (IHI) in Parkinson’s disease…
  • 2023 International Congress

    Challenges in the measurement of brain iron deposition in Parkinson’s disease in non-academic research settings.

    B. Kashyap, K. Wyman-Chick, L. Hanson, S. Gustafson, S. Sherman, W. Frey, Ii, J. Johnson (St Paul, USA)

    Objective: Assess the feasibility of detecting brain iron deposition using quantitative susceptibility mapping (QSM) among patients with Parkinson’s disease (PD) in a community-based clinic setting.…
  • 2023 International Congress

    A portable and distributable measure of temporal discrimination: an objective means for diagnosis of cervical dystonia.

    SR. Bostan, C. Fearon, M. Hutchinson, R. Reilly (Dublin, Ireland)

    Objective: Despite the high prevalence, devastating impact to patient quality of life and substantial cost burden on society, dystonia is still poorly understood. The lack…
  • 2023 International Congress

    Idiopathic Intracranial Hypertension as the presenting symptom in Wilson’s Disease: how is it possible?

    V. Mesquita, F. Rolim, A. Gomes, R. Carvalho, P. Matos, A. Marinho, N. Frota, F. Carvalho (Fortaleza, Brazil)

    Objective: To report a patient with Wilson’s disease (WD) who became symptomatic shortly after presenting Idiopathic Intracranial Hypertension (HII). Background: WD’s pleomorphic clinical phenotype remains…
  • 2023 International Congress

    Proposed model for the delivery of tertiary-care, interdisciplinary tremor evaluations.

    D. Roque, V. Krishna, M. Collins, J. Ferrall, N. Sharma (Chapel Hill, USA)

    Objective: To present the design and implementation of a proposed solution to handle tertiary-care evaluations for patients with tremor; providing comprehensive recommendations effectively communicated to…
  • 2023 International Congress

    Effect of lower level laser therapy for neurogenic or non-neurogenic overactive bladder

    T. Uchiyama, T. Yamamoto, R. Sakakibara, S. Kuwabara, H. Murai (Chiba, Japan)

    Objective: To evaluate the effect of lower level laser therapy for neurogenic or non-neurogenic overactive bladder (OAB) Background: There are many patients with OAB in…
  • « Previous Page
  • 1
  • …
  • 21
  • 22
  • 23
  • 24
  • 25
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley